Screener
USANA Health Sciences USNA Total Revenue
Discontinued — last reported Q1 '26
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Net sales | $250,218 | $249,539 |
| Cost of sales | 59,436 | 52,445 |
| Gross profit | 190,782 | 197,094 |
| Operating expenses: | ||
| Brand Partner incentives | 88,654 | 89,985 |
| Selling, general and administrative | 88,254 | 91,438 |
| Total operating expenses | 176,908 | 181,423 |
| Earnings from operations | 13,874 | 15,671 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's total revenue?
- USANA Health Sciences (USNA) reported total revenue of $250.22M in Q1 2026.
- How has USANA Health Sciences's total revenue changed year-over-year?
- USANA Health Sciences's total revenue increased by 0.3% year-over-year, from $249.54M to $250.22M.
- What is the long-term trend for USANA Health Sciences's total revenue?
- Over 4 years (2021 to 2025), USANA Health Sciences's total revenue has grown at a -6.0% compound annual growth rate (CAGR), from $1.19B to $925.26M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about USANA Health Sciences's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude